ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1861

Use of a Novel Electronic Auto-notification Process to Manage Transitions of Care in Rheumatic Patients on DMARD Therapy

Megan Bielawski1, Eric Newman 2 and Lisa Schroeder 1, 1Geisinger Medical Center, Danville, PA, 2Geisinger, Danville, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Biologics and surgery, Communication, DMARDs

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M112: Measures of Healthcare Quality I: Digital Health Technologies – Tool for Improvement (1860–1865)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatologic diseases. In our prior study of rheumatoid arthritis patients and hospital admissions, our rheumatologists were only notified 57.6% of the time. This project’s goal was to integrate an auto-notification system into our clinical workflow, so that timely communication of sentinel events (Elective surgery, Hospital admission, or ER visit) in immunosuppressed rheumatic disease patients happens by design, not by accident.

Methods: We developed an algorithm that triggers an auto-notification to the Rheumatology Nurse Navigator when a patient of interest (POI) experiences a sentinel event. A POI has been seen by a rheumatologist at least twice within the past 14 months and takes a DMARD or glucocorticoid. The Nurse Navigator creates a telephone encounter that includes the event type, baseline glucocorticoid and DMARD therapy, and event date. That encounter is forwarded to the rheumatologist, who records recommendations based on current guidelines and returns it to the Nurse Navigator, who notifies the patient or other providers of the recommendations.

Results: During the four-month study period, 240 completed notifications were received – 57% for elective surgeries, 39% for ER visits, and 4% for admissions. The need for change in care plan was less common for ER visits (17%), but was 25% for hospital admissions and 44% for elective surgeries. A significant result is the time interval between receipt of the notification and the date of elective surgery. This is applicable to our patients taking biologic DMARDs and/or high dose glucocorticoids, as these medications may require holding or adjusting a dose weeks before surgery. The mean number of days in this interval was 23. Therefore, this notification process is useful in the case of medications that need to be held or adjusted three weeks or less prior to surgery. The time commitment by clinicians has been minimal. The nurse spent an average of 5 minutes for each patient and the physicians spent an average of 5.9 minutes. The percentage of time that clinicians were notified of sentinel events increased from 57.6% to 100%.

Conclusion: Without knowledge of the care team, and no communication process integrated into the clinical workflow, communication and care handoff failures are extremely common. We developed a process that “hardwires” notification of the specialist for a patient sentinel event, to facilitate timely and relevant care. The average number of messages that clinicians received per week was 2.2. Since the average number of minutes clinicians spent per message was 5.9, this resulted in only 13 minutes of work for each clinician per week, making this a very manageable process.  With this automated program, care communication failures fell from 42.4% to 0%. As changes to the care plan were needed 34% of the time, this notification is crucial to our patient care. The process is easy, reliable, and has been well-received. As the program has been effective in improving patient care and outcomes, other divisions in our institution, such as Pulmonary, are developing a similar program for their patient population.


Disclosure: M. Bielawski, None; E. Newman, None; L. Schroeder, None.

To cite this abstract in AMA style:

Bielawski M, Newman E, Schroeder L. Use of a Novel Electronic Auto-notification Process to Manage Transitions of Care in Rheumatic Patients on DMARD Therapy [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/use-of-a-novel-electronic-auto-notification-process-to-manage-transitions-of-care-in-rheumatic-patients-on-dmard-therapy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-a-novel-electronic-auto-notification-process-to-manage-transitions-of-care-in-rheumatic-patients-on-dmard-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology